Aurinia Pharmaceuticals Inc. (AUPH) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $15.46 (+0.52%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Sep 6, 2024 | Ed Arce | H.C. Wainwright | $13.00 | -15.9% |
| May 2, 2024 | Maury Raycroft | Jefferies | $6.00 | -61.2% |
Top Analysts Covering AUPH
AUPH vs Sector & Market
| Metric | AUPH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +0.2% | +1150.3% | +14.9% |
| P/E Ratio | 7.47 | 6.86 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $79M | $81M | $84M | 5 |
| 2026-09-30 | $81M | $83M | $87M | 2 |
| 2026-12-31 | $83M | $86M | $90M | 2 |
| 2027-12-31 | $366M | $384M | $413M | 5 |
| 2028-12-31 | $426M | $443M | $485M | 5 |
| 2029-12-31 | $448M | $466M | $510M | 2 |
| 2030-12-31 | $497M | $517M | $565M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.18 | $0.20 | $0.24 | 3 |
| 2026-09-30 | $0.20 | $0.21 | $0.22 | 1 |
| 2026-12-31 | $0.20 | $0.21 | $0.22 | 1 |
| 2027-12-31 | $0.67 | $1.06 | $1.46 | 4 |
| 2028-12-31 | $0.43 | $1.27 | $2.12 | 4 |
| 2029-12-31 | $1.19 | $1.26 | $1.41 | 2 |
| 2030-12-31 | $1.56 | $1.64 | $1.84 | 2 |
Frequently Asked Questions
What is the analyst consensus for AUPH?
The consensus among 3 analysts covering Aurinia Pharmaceuticals Inc. (AUPH) is Hold with an average price target of $15.50.
What is the highest price target for AUPH?
The highest price target for AUPH is $13.00, set by Ed Arce at H.C. Wainwright on 2024-09-06.
What is the lowest price target for AUPH?
The lowest price target for AUPH is $6.00, set by Maury Raycroft at Jefferies on 2024-05-02.
How many analysts cover AUPH?
3 analysts have issued ratings for Aurinia Pharmaceuticals Inc. in the past 12 months.
Is AUPH a buy or sell right now?
Based on 3 analyst ratings, AUPH has a consensus rating of Hold (2.67/5) with a +0.2% upside to the consensus target of $15.50.
What are the earnings estimates for AUPH?
Analysts estimate AUPH will report EPS of $0.20 for the period ending 2026-06-30, with revenue estimated at $81M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.